David Emerson Jorden Nuo Therapeutics, Inc. (AURX) insider trading activity

AURX Quotes by TradingView

David Emerson Jorden is CEO/CFO of Nuo Therapeutics, Inc.. Currently has a direct ownership of 2.15 Million shares of AURX, which is worth approximately $3.22 Million. The most recent transaction as insider was on Aug 01, 2025, when has been sold 21,313 shares (Common Stock) at a price of $1.74 per share, resulting in proceeds of $37,084. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.15M
8.68% 3M change
8.68% 12M change
Total Value Held $3.22 Million

DAVID EMERSON JORDEN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 01 2025
SELL
Payment of exercise price or tax liability
$37,084 $1.74 p/Share
21,313 Reduced 0.98%
2,146,755 Common Stock
Aug 01 2025
BUY
Exercise of conversion of derivative security
$77,084 $0.4 p/Share
192,710 Added 8.16%
2,168,068 Common Stock
Nov 09 2022
SELL
Open market or private sale
$243,750 $1.5 p/Share
162,500 Reduced 7.6%
1,975,358 Common Stock
Apr 29 2022
BUY
Grant, award, or other acquisition
$10,532 $1.0 p/Share
10,532 Added 0.49%
2,137,858 Common Stock
DEJ

David Emerson Jorden

CEO/CFO
Houston, TX

Track Institutional and Insider Activities on AURX

Follow Nuo Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AURX shares.

Notify only if

Insider Trading

Get notified when an Nuo Therapeutics, Inc. insider buys or sells AURX shares.

Notify only if

News

Receive news related to Nuo Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AURX